Atazanavir 150 MG Oral Capsule [Reyataz] is an antiviral medication that prevents human immunodeficiency virus cells from multiplying in your body. Atazanavir 150 MG Oral Capsule [Reyataz] is used with other medications to treat HIV, which causes the acquired immunodeficiency syndrome (AIDS). Atazanavir 150 MG Oral Capsule [Reyataz] is not a cure for HIV or AIDS. Atazanavir 150 MG Oral Capsule [Reyataz] may also be used for purposes not listed in Atazanavir 150 MG Oral Capsule [Reyataz] guide.
Atazanavir 150 MG Oral Capsule [Reyataz] side effects
Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat. Atazanavir 150 MG Oral Capsule [Reyataz] may increase your risk of certain infections or autoimmune disorders by changing the way your immune system works. Symptoms may occur weeks or months after you start treatment with Atazanavir 150 MG Oral Capsule [Reyataz]. Tell your doctor if you have:
signs of a new infection--fever, night sweats, swollen glands, diarrhea, stomach pain, weight loss;
chest pain (especially when you breathe), dry cough, wheezing, feeling short of breath;
cold sores, sores on your genital or anal area;
rapid heart rate, feeling anxious or irritable, weakness or prickly feeling, problems with balance or eye movement;
trouble speaking or swallowing, severe lower back pain, loss of bladder or bowel control; or
swelling in your neck or throat (enlarged thyroid), menstrual changes, impotence, loss of interest in sex.
Stop taking Atazanavir 150 MG Oral Capsule [Reyataz] and call your doctor at once if you have:
headache with chest pain and severe dizziness, fainting, fast or pounding heartbeats;
severe pain in your side or lower back, painful urination, blood in your urine;
jaundice (yellowing of the skin or eyes);
high blood sugar (increased thirst, increased urination, hunger, dry mouth, fruity breath odor, drowsiness, dry skin, blurred vision); or
severe skin reaction -- fever, sore throat, swelling in your face or tongue, burning in your eyes, skin pain, followed by a red or purple skin rash that spreads (especially in the face or upper body) and causes blistering and peeling.
numbness or burning pain in your hands or feet; or
changes in the shape or location of body fat (especially in your arms, legs, face, neck, breasts, and waist).
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088. See also: Side effects (in more detail)
Atazanavir 150 MG Oral Capsule [Reyataz] dosing
Usual Adult Dose for HIV Infection:
THERAPY-NAIVE PATIENTS: -Recommended dose: Atazanavir 150 MG Oral Capsule [Reyataz] 300 mg plus ritonavir 100 mg orally once a day -If unable to tolerate ritonavir: 400 mg orally once a day -If used with efavirenz: Atazanavir 150 MG Oral Capsule [Reyataz] 400 mg plus ritonavir 100 mg orally once a day THERAPY-EXPERIENCED PATIENTS: -Recommended dose: Atazanavir 150 MG Oral Capsule [Reyataz] 300 mg plus ritonavir 100 mg orally once a day -If used with both an H2-receptor antagonist and tenofovir: Atazanavir 150 MG Oral Capsule [Reyataz] 400 mg plus ritonavir 100 mg orally once a day PREGNANCY: Therapy-naive and Therapy-experienced Patients: -Recommended dose: Atazanavir 150 MG Oral Capsule [Reyataz] 300 mg plus ritonavir 100 mg orally once a day Therapy-experienced Patients during the Second or Third Trimester: -If used with either an H2-receptor antagonist or tenofovir: Atazanavir 150 MG Oral Capsule [Reyataz] 400 mg plus ritonavir 100 mg orally once a day -If used with both an H2-receptor antagonist and tenofovir: Not recommended. Comments: -This drug must be used with ritonavir during pregnancy. -This drug should only be used in pregnant women with HIV-1 strains susceptible to Atazanavir 150 MG Oral Capsule [Reyataz]. -No dose adjustment needed for pregnant patients with the above exceptions. -No dose adjustment needed for postpartum patients; close monitoring for side effects recommended. Use: In combination with other antiretroviral agents, for the treatment of HIV-1 infection
Usual Adult Dose for Nonoccupational Exposure:
US CDC recommendations: -Recommended dose: 400 mg orally once a day -If used with tenofovir: Atazanavir 150 MG Oral Capsule [Reyataz] 300 mg plus ritonavir 100 mg orally once a day Duration of therapy: 28 days Comments: -Recommended as an alternative regimen for nonoccupational postexposure prophylaxis of HIV infection -This drug should be used with (lamivudine or emtricitabine) plus (zidovudine or stavudine or abacavir or didanosine) or (tenofovir plus ritonavir [100 mg/day]). -Prophylaxis should be started as soon as possible, within 72 hours of exposure. -Not approved by US FDA.
Usual Pediatric Dose for HIV Infection:
ORAL POWDER: Therapy-naive and Therapy-experienced Patients: 3 months or older: 10 to less than 15 kg: Atazanavir 150 MG Oral Capsule [Reyataz] 200 mg plus ritonavir 80 mg orally once a day 15 to less than 25 kg: Atazanavir 150 MG Oral Capsule [Reyataz] 250 mg plus ritonavir 80 mg orally once a day CAPSULES: Therapy-naive and Therapy-experienced Patients: 6 to less than 18 years: 15 to less than 20 kg: Atazanavir 150 MG Oral Capsule [Reyataz] 150 mg plus ritonavir 100 mg orally once a day 20 to less than 40 kg: Atazanavir 150 MG Oral Capsule [Reyataz] 200 mg plus ritonavir 100 mg orally once a day 40 or more: Atazanavir 150 MG Oral Capsule [Reyataz] 300 mg plus ritonavir 100 mg orally once a day Therapy-naive Patients Unable to Tolerate Ritonavir: 13 to less than 18 years: 40 kg or more: 400 mg orally once a day Comments: -Each packet of the oral powder contains 50 mg of Atazanavir 150 MG Oral Capsule [Reyataz]. -The oral powder should be administered after mixing with food or beverage; ritonavir should be administered immediately after that. -The oral powder is not recommended for patients weighing less than 10 kg or 25 kg or more. -The capsules and ritonavir should be administered simultaneously with food. -The capsules must be used with ritonavir in therapy-experienced patients. -According to the Panel on Antiretroviral Therapy and Medical Management of HIV-infected Children, some experts recommend increasing Atazanavir 150 MG Oral Capsule [Reyataz] to 300 mg at a weight of at least 35 kg to avoid underdosing, especially when tenofovir is coadministered. Use: In combination with other antiretroviral agents, for the treatment of HIV-1 infection
Can Atazanavir 150 MG Oral Capsule [Reyataz] be stopped immediately or do I have to stop the consumption gradually to ween off?
In some cases, it always advisable to stop the intake of some medicines gradually because of the rebound effect of the medicine.
It's wise to get in touch with your doctor as a professional advice is needed in this case regarding your health, medications and further recommendation to give you a stable health condition.
Who should not take Atazanavir 150 MG Oral Capsule [Reyataz]?
You should not use this medicine if you have ever had a severe allergic reaction to Atazanavir 150 MG Oral Capsule [Reyataz].
Some medicines can cause unwanted or dangerous effects when used with Atazanavir 150 MG Oral Capsule [Reyataz]. Your doctor may need to change your treatment plan if you use any of the following drugs:
To make sure Atazanavir 150 MG Oral Capsule [Reyataz] is safe for you, tell your doctor if you have:
liver disease, hepatitis B or C;
kidney disease (or if you are on dialysis);
history of kidney stones or gallstones;
diabetes;
a bleeding disorder such as hemophilia;
high cholesterol or triglycerides;
a heart rhythm disorder, a heart condition called "AV block"; or
if you have ever used a protease inhibitor in the past.
FDA pregnancy category B. Atazanavir 150 MG Oral Capsule [Reyataz] is not expected to be harmful to an unborn baby, but HIV can be passed to your baby if you are not properly treated during pregnancy. Take all of your HIV medicines as directed to control your infection. Atazanavir 150 MG Oral Capsule [Reyataz] must be given together with ritonavir during pregnancy and for a short time after childbirth. Follow your doctor's dosing instructions very carefully.
Atazanavir 150 MG Oral Capsule [Reyataz] can make birth control pills, patches, injections, or vaginal rings less effective. Ask your doctor about using a non-hormone method of birth control (such as a condom, diaphragm, spermicide) to prevent pregnancy while taking Atazanavir 150 MG Oral Capsule [Reyataz].
Women with HIV or AIDS should not breast-feed a baby. Even if your baby is born without HIV, the virus may be passed to the baby in your breast milk.
Do not give this medication to a child younger than 6 years old. Do not give Atazanavir 150 MG Oral Capsule [Reyataz] alone (without ritonavir) to a child younger than 13 years old, or to a child who weighs less than 88 pounds.
What other drugs will affect Atazanavir 150 MG Oral Capsule [Reyataz]?
Many drugs can interact with Atazanavir 150 MG Oral Capsule [Reyataz]. Not all possible interactions are listed here. Tell your doctor about all your medications and any you start or stop using during treatment with Atazanavir 150 MG Oral Capsule [Reyataz], especially:
bosentan;
buprenorphine;
colchicine;
fluticasone (especially if you also take ritonavir);
paclitaxel;
repaglinide;
salmeterol (with or without fluticasone);
warfarin (Coumadin);
other HIV/AIDS medications;
the hepatitis C medications boceprevir or telaprevir;
an antibiotic--clarithromycin, rifabutin;
an antidepressant--amitriptyline, doxepin, desipramine, imipramine, protriptyline, trazodone, trimipramine;
This list is not complete and many other drugs can interact with Atazanavir 150 MG Oral Capsule [Reyataz]. This includes prescription and over-the-counter medicines, vitamins, and herbal products. Give a list of all your medicines to any healthcare provider who treats you.
How should I take Atazanavir 150 MG Oral Capsule [Reyataz]?
Follow all directions on your prescription label. Do not take this medicine in larger or smaller amounts or for longer than recommended. Atazanavir 150 MG Oral Capsule [Reyataz] is often used together with another medicine called ritonavir (Norvir).
Atazanavir 150 MG Oral Capsule [Reyataz] should be taken once daily with food. Swallow the capsule whole.
Use Atazanavir 150 MG Oral Capsule [Reyataz] regularly to get the most benefit. Get your prescription refilled before you run out of medicine completely.
While using Atazanavir 150 MG Oral Capsule [Reyataz], you may need frequent blood tests at your doctor's office. Your liver function may also need to be checked.
HIV/AIDS is usually treated with a combination of drugs. Use all medications as directed by your doctor. Read the medication guide or patient instructions provided with each medication. Do not change your doses or medication schedule without your doctor's advice. Every person with HIV or AIDS should remain under the care of a doctor.
Store at room temperature away from moisture and heat.
Can Atazanavir 150 MG Oral Capsule [Reyataz] be taken or consumed while pregnant?
Please visit your doctor for a recommendation as such case requires special attention.
Can Atazanavir 150 MG Oral Capsule [Reyataz] be taken for nursing mothers or during breastfeeding?
Kindly explain your state and condition to your doctor and seek medical advice from an expert.
Reviews
Following the study conducted by gmedication.com on Atazanavir 150 MG Oral Capsule [Reyataz], the result is highlighted below. However, it must be clearly stated that the survey and result is based solely on the perception and impression of visitors and users of the website as well as consumers of Atazanavir 150 MG Oral Capsule [Reyataz]. We, therefore, urge readers not to base their medical judgment strictly on the result of this study but on test/diagnosis duly conducted by a certified medical practitioners or physician.
Patient reports
Patient reported useful
No survey data has been collected yet
Patient reported side effects
No survey data has been collected yet
Patient reported price estimates
No survey data has been collected yet
Patient reported frequency of use
No survey data has been collected yet
Patient reported doses
No survey data has been collected yet
Patient reported time for results
No survey data has been collected yet
Patient reported administration
No survey data has been collected yet
Patient reported age
No survey data has been collected yet
Patient reviews
There are no reviews yet. Be the first to write one!